PAH patients with cardiovascular disease risk had similar hospitalization and mortality rates as those without after a ...

Columnist Colleen Steele says that glimmers are like an antidote to some of the events that spark her caregiving anxiety.

Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...

Columnist Anna Jeter is delighted to find themes that are relevant to her life in the fictional narratives of writers and ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

Adding Winrevair treatment significantly reduced the risk of clinical worsening in people with a recent PAH diagnosis, per a ...

With patient enrollment now complete, topline results are expected early next year from a Phase 3 trial testing PAH treatment ...

Acceptance into the FDA’s Total Product Life Cycle Advisory Program (TAP) pilot will give the company more opportunities to interact with regulatory authorities. It comes after the company’s Gradient ...